Dudediligence.

Novavax, Inc

NVAXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
OptionsOpen the Sheet →FilingsNewest: 13G, Stake over 5%, passiveAug 7 →InsidersNo open-market buys or sales.→Financing →PeersClosest companies: PCVX, IVVD, VIR→

From the filings

Figures

Revenue
$413.8Mlast 12 months
Net income
−$247.7Mlast 12 months
Operating cash flow
−$91.6Mlast 12 months
Cash and equivalents
$191.5Mat the last balance sheet
Total debt
$291.5Mat the last balance sheet
Shares outstanding
164.8M shareson issue
Every year and quarter →